Chad Watkins

Chad Watkins possesses extensive experience in business development and leadership within the pharmaceutical and healthcare sectors. Currently, Chad serves as the General Manager of Isotope Strategy and Vice President of Business Development at Telix Pharmaceuticals Limited since July 2022. Previously, Chad held significant roles such as Global Director of Business Development for therapeutics at SHINE Medical Technologies, LLC, and General Counsel at Radiology Services of Northern Virginia. Additionally, Chad co-founded Abel Sports Management, a boutique sports agency, where responsibilities included advising and representing athletes. Chad holds a Doctor of Law (JD) from George Mason University and a Bachelor of Science (BS) in Finance from Virginia Tech.